← Oncology Approval Tracker

FDA DECISION ·

Romidepsin (generic Istodax)

romidepsin · Fresenius Kabi

First generic approvalFirst genericCutaneous T-cell lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic romidepsin injection for adults with cutaneous T-cell lymphoma following at least one prior systemic treatment.

LAMPGEN ANALYSIS

Why it matters

The ANDA action applies to cutaneous T-cell lymphoma after prior therapy.

What research teams should watch

Confirm cutaneous histology and previous systemic therapy before applying the generic label.

PRIMARY RECORDS

Sources